2Lebwohl M. A clinicians paradigm in the treatment of psoria- sis[J]. J Am Acad Dermatol, 2005,53 ( 1 Suppl 1) : $59 69.
3Arehier E, Devaux S, Castela E, et al. Efficacy of psoralen UV-A therapy vs narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review[J]. J Eur Acad Der matol Venereol,2012,26(Suppl 3) :11-21.
4Debbaneh MG, Levin E, Sanchez Rodriguez R,et al. Plaque- based sub-blistering dosimetry: reaching PASI 75 after two treatments with 308-nm excimer laser in a generalized psoria sis patient[J]. J Dermatolog Treat,2014,20 : 1-4.
5Horwitz SN, Johnson RA, Sefton J,et al. Addition of a topi- cally applied corticosteroid to a modified Goeekerman regimen for treatment of psoriasis： effect on duration of remission[J]. J Am Acad Dermatol,1985,13(5 Pt 1):784 791.
6Seitfi S, Khemis A, Rougier A,et al. Emollient for mainte nance therapy after topical corticotherapy in mild psoriasis [J]. Exp Dermatol,2009, 18(12) : 1076-I078.
7Pathirana D, Ormerod AD, Saiag P, et al. European S3- guidelines on the systemic treatment of psoriasis vulgaris[J]. Euro Acad Dermatol Venereol, 2009,24 (1) : 117 118.
8Khaled A, Ben Hamida M, Zeglaoui F, et al. Treatment of psoriasis by methotrexate in the era of biotherapies: a study in 21 Tunisian patients[J]. Therapie ,2012,67(1) :49-52.
9Colombo D, Cassano N, Altomare G,et al. Psoriasis relapse evaluation with week-end cyclosporine A treatment., results of a randomized, double-blind, multicenter study[J]. Int J Immunopathol Pharmacol,2010,23(4) :1143-1152.
10Koo J, Lebwohl M. Duration of remission of psoriasis thera- pies[J]. J Am Aead Dermatol, 1999,41 ( 1 ) : 51-59.
